Skip to content
Advertisement

Business Paid

Ryvu summarizes the year 2022

21:29

Ryvu summarizes the year 2022
Source: Ryvu Therapeutics

In December 2022, Ryvu conducted a public offering of 4,764,674 series J shares, which exceeded the value of PLN 250 million. The transaction was participated by the largest Polish pension and investment funds, as well as individual and industry investors, including the Leukemia & Lymphoma Society Therapy Acceleration Program, the world's largest and prestigious foundation dedicated to fighting blood cancers, and…

This article is for subscribers

Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.

Subscribe

Or try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.

Already a subscriber? Sign in · No account? Join now

More from Business All